61
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Immunoglobulin Light Chain Kappa Deletion Rearrangement as a Marker of Clonality in Mantle Cell Lymphoma

, , , , , , & show all
Pages 147-150 | Received 10 May 1999, Published online: 01 Jul 2009
 

Abstract

Mantle cell lymphoma (MCL) express immunoglobulin light chain h (IgL-h) more frequently than other non-Hodgkin's lymphomas, and IgL-h producing B-cells usually delete one or both alleles of their IgL-K genes. This inactivation is mediated by a rearrangement between the k deletion element (Kde) and the Recombinant Signal Sequence (RSS) in the region between the Joining genes and the Constant region, or the RSS at the 3′-site of a Variable (Vk) segment. This deletion appears as a feasible tool for detecting monoclonality and minimal residual disease by polymerase chain reaction (PCR). Among twelve MCL patients studied, ten presented IgL-K expression, and all but one among these revealed a monoclonal Kde rearrangement by PCR analysis. Six of the nine cases showed a fusion between the Kde and the intron RSS, whilst three with a Vk segment. Since MCL has the worst prognosis of all B-cell lymphomas and high-dose chemotherapy regimens have been proposed, PCR for the Kde rearrangement might be a useful molecular tool to evaluate the ability of the different treatment modalities to eradicate the malignant clones.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.